Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam

AIDS Research and Human Retroviruses

Volumn 21, Issue 6, 2005, Pages 586-591

  Lazaro, Estibaliz ^a   Theodorou, Ioannis ^b   Legrand, Elisabeth ^a,d   Recordon Pinson, Patricia ^a   Boucher, Sebastien ^a   Capoulade, Corinne ^b   Lan, Thi Hoang ^c   Van Hung, Pham ^c   Debre, Patrice ^b   Fleury, Herve ^a  

^a University Victor Segalen   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Health Service   (Viet Nam)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; NEF PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG DESIGN; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIET NAM;

EID: 21744432185     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.586     Document Type: Article

References (20)

1. Tran TT, Maljkovic I, Swarding S, Phung DC, Chiodi F, and Leitner T: HIV-1 CRF01_AE in intravenous drug users in Hanoi, Vietnam. AIDS Res Hum Retroviruses 2004;20(3):341-345.
2. ONUSIDA/OMS: AIDS epidemic update: December 2003.
3. Lan NT, Recordon-Pinson P, Hung PV, et al.: HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. AIDS Res Hum Retroviruses 2003;19(10):925-928.
4. Novitsky V, Cao H, Rybak N, et al.: Magnitude and frequency of cytotoxic T-lymphocyte responses: Identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol 2002;76(20):10155-10168.
5. Yu XG, Addo MM, Perkins BA, et al.: Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and Caucasians. AIDS Res Hum Retroviruses 2004;20(5):557-564.
6. Bansal A, Sabbaj S, Edwards BH, et al: T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles. AIDS Res Hum Retroviruses 2003;19(11):1017-1026.
7. Frahm N, Korber BT, Adams CM, et al.: Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004; 78(5):2187-2200.
8. Gahery-Segard H, Pialoux G, Figueiredo S, et al.: Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: Characterization of CD8+-T-cell epitopes recognized. J Virol 2003;77(20):11220-11231.
9. Inwoley A, Recordon P, Minga A, et al.: Cross-reactive HIV-1 clade B CD8 T-lymphocytes in patients infected with HIV-1 subtypeA/G(CRFO2) living in Ivory Coast (West Africa). 10th Conference on Retroviruses and Opportunistic Infections, February 10-14, 2003, Boston, MA. Abstract 324.
10. Leslie AJ, Pfafferott KJ, Chetty P, et al.: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10(3):282-289.
11. Choppin J, Cohen W, Bianco A, et al: Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: Wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol 2001;166(10):6164-6169.
12. Parker KC, Bednarek MA, and Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994;152:163-175.
13. Falk K, Rötzschke O, Stevanovic S, Jung G, and Rammemsee HG: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-296.
14. Samri A, Haas G, Duntze J, et al: Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. J Virol 2000;74(19):9306-9312.
15. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3(2):205-211.
16. Goulder PJ, Brander C, Tang Y, et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001;412(6844):334-338.
17. Yang OO, Sarkis PT, Ali A, et al.: Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med 2003; 197(10):1365-1375.
18. Gorochov G, Neumann AU, Kereveur A, et al: Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998;4(2):215-221.
19. Moore CB, John M, James IR, et al: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002;296:1439-1443.
20. Friedrich TC, Dodds EJ, Yant LJ, et al.: Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 2004; 10(3):275-281.